Heterohybridoma for the production of non murine monoclonal antibodies
Hybridoma technology described by kohler and Milstein produce only mouse immunoglobulins. Such immunoglobulins have limited use due to its negative side effects such as the recipient’s immune response. The production of a non murine monoclonal antibody to combat the problems of murine...
Main Author: | Kh.Victoria Chanu and M. Ayub Ali |
---|---|
Format: | Article |
Language: | English |
Published: |
Veterinary World
2010-01-01
|
Series: | Veterinary World |
Subjects: | |
Online Access: | http://www.scopemed.org/mnstemps/2/2-1286562301.pdf |
Similar Items
-
Two new murine monoclonal antibodies rised against human IgG
by: Petrićević Marijana, et al.
Published: (2001-01-01) -
Two new murine monoclonal antibodies rised against human IgG
by: RATKO M. JANKOV, et al.
Published: (2001-05-01) -
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
by: Jakub Radocha, et al.
Published: (2021-03-01) -
Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01) -
Monoclonal Antibodies: The Greatest Resource to Treat Multiple Myeloma
by: Fabiola De Luca, et al.
Published: (2023-02-01)